×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Index: Diseases
index
3,070 words
2026-03-24
kind:index
section:diseases
Contents
Diseases
Related Hypotheses (30)
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P
Score: 0.64
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Closed-loop tACS targeting entorhinal cortex layer II SST in
Score: 0.62
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph
Score: 0.61
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener
Score: 0.61
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Multi-Modal Stress Response Harmonization
Score: 0.60
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Microbial Inflammasome Priming Prevention
Score: 0.58
Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N
Score: 0.58
Context-Dependent Cx43 Modulation Based on Disease Stage
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes
Score: 0.57
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Smartphone-Detected Motor Variability Correction
Score: 0.56
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S
Score: 0.55
Show 25 more
Related Analyses (30)
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
How do pathological stress granules transition from reversib
neurodegeneration · failed
How does TRIM21-mediated K63 ubiquitination of G3BP1 mechani
neurodegeneration · failed
How do different organelle-specific autophagy pathways coord
neurodegeneration · failed
What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed
What determines organelle-specific autophagy selectivity in
neurodegeneration · failed
What molecular mechanisms drive tissue-specific phenotypes i
neurodegeneration · completed
What determines the specificity of DDR protein recruitment t
neurodegeneration · completed
Are autophagy-lysosome defects primary drivers or downstream
neurodegeneration · failed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Show 25 more
Related Experiments (30)
Oxidative stress induction in human chondrocytes with t-BHP
exploratory · proposed · Score: 0.90
TRIM21 E3 ubiquitin ligase screen for stress granule regulat
exploratory · proposed · Score: 0.90
TFEB silencing and misfolded protein degradation
exploratory · proposed · Score: 0.88
Tissue-specific interaction network inference
exploratory · proposed · Score: 0.85
Tissue-specific network analysis of Mendelian diseases
exploratory · proposed · Score: 0.85
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.46
s:** - ALOX15 overexpression in healthy astrocytes should be
falsification · proposed · Score: 0.46
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.46
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.46
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.46
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.46
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46
Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.46
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.46
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.46
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.46
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.46
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.46
Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.46
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46
Cholinergic System Dysfunction in DLB — Mechanisms and Thera
clinical · proposed · Score: 0.46
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.46
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.46
Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.46
FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.46
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.46
Show 25 more
Knowledge Graph (8 edges)
SOCIAL_DISADVANTAGE
activates
AGE_RELATED_DISEASES
HSPA1A
associated_with
AGE_RELATED_DISEASES
BDNF
treats
NEUROLOGICAL_DISEASES
BDNF
treats
PSYCHIATRIC_DISEASES
IL6
associated_with
AUTOIMMUNE_DISEASES
PROTEIN_AGGREGATION
contributes_to
NEURODEGENERATIVE_DISEASES
DNA_DAMAGE
contributes_to
NEURODEGENERATIVE_DISEASES
MITOCHONDRIAL_DYSFUNCTION
causes
NEURODEGENERATIVE_DISEASES